Six-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancer.

MLA

Hayashi, Satoshi, et al. “Six-Transmembrane Epithelial Antigen of the Prostate and Enhancer of Zeste Homolog 2 as Immunotherapeutic Targets for Lung Cancer.” Journal of Translational Medicine, vol. 9, Nov. 2011, p. 191. EBSCOhost, https://doi.org/10.1186/1479-5876-9-191.

APA

Hayashi, S., Kumai, T., Matsuda, Y., Aoki, N., Sato, K., Kimura, S., Kitada, M., Tateno, M., Celis, E., & Kobayashi, H. (2011). Six-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancer. Journal of Translational Medicine, 9, 191. https://doi.org/10.1186/1479-5876-9-191

Chicago

Hayashi, Satoshi, Takumi Kumai, Yoshiya Matsuda, Naoko Aoki, Keisuke Sato, Shoji Kimura, Masahiro Kitada, Masatoshi Tateno, Esteban Celis, and Hiroya Kobayashi. 2011. “Six-Transmembrane Epithelial Antigen of the Prostate and Enhancer of Zeste Homolog 2 as Immunotherapeutic Targets for Lung Cancer.” Journal of Translational Medicine 9 (November): 191. doi:10.1186/1479-5876-9-191.